Australia Revises GMPs for Human Blood, Tissue Products

Australia’s Therapeutic Goods Administration (TGA) released revisions to 2,000 good manufacturing practice (GMP) codes that apply to biologic drugs, blood and tissue components and cellular therapy products.
Drug Industry Daily